Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proteolix Inc.

Division of Amgen Inc.
www.proteolix.com

Latest From Proteolix Inc.

Tocagen Names Lori Kunkel To Board

Tocagen Inc., a clinical-stage immuno-oncology company, has appointed Lori Kunkel to its board of directors. With more than 20 years' experience in oncology and immunology drug development, Kunkel is currently on the board of Loxo Oncology. Prior to this, she was chief medical officer of Pharmacyclics (acquired by AbbVie) and Proteolix Inc (acquired by Onyx Pharmaceuticals). She was also vice-president of clinical development at Xencor, Inc.

Companies

Will Yeast Lead The Way To Parkinson’s Disease Drugs? An Interview With Tony Coles Of Yumanity Therapeutics

The duo behind Yumanity brings to it multiple successes measured by basic science discoveries, new drugs for patients, and billions made for investors. Can they do it again with their novel approach for discovering neurodegenerative disease drugs?

BioPharmaceutical

Financings Of The Fortnight Wonders How Wide-Open Is The Window?

The beginnings of ominous signs are appearing in the flourishing biotech IPO market. Plus news on recent financings by Foundation Medicine, Arvinas, Moderna Therapeutics and Frazier Healthcare.

Business Strategies

VCs Put $15M Into New Start-Up From Proteolix Founder

The biotech, Arvinas, will pursue therapies that degrade proteins, a process that could lead to therapeutic approaches to targets previously thought to be undruggable. The $15 million in venture funding is augmented by $3.5 million from the state of Connecticut.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Amgen Inc.
  • Senior Management
  • Craig C Parker, SVP, Fin. & Corp. Dev. & CFO
    Mark K Bennett, PhD, VP, Research
  • Contact Info
  • Proteolix Inc.
    Phone: (650) 266-2600
    333 Allerton Ave.
    S. San Francisco, CA 94080
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register